Cooper, Donald A. et al., Biological Mass Spectrometry, vol. 22, (1993). |
Pinner, A., Chem. Ber., pp. 1053-1061 (1894). |
Pinner, A., Chem. Ber., pp. 2861-2870 (1894). |
LaForge, F., JACS, vol. 50, pp. 2477-2483 (1928). |
Acheson, R. et al., J. Chem. Soc. Perkin Trans., vol. 2, pp. 579-585 (1980). |
Loffler, K. et al., Chem. Ber., vol. 42, pp. 3431-3438 (1909). |
Joyce, N. J. et al., Heterocycles, vol. 29, No. 7, pp. 1335-1342 (1978). |
Frank, W. et al., J. Org. Chem., vol. 43(15), pp. 2947-2949 (1978). |
Malek, N. et al., J. Org. Chem., vol. 47, pp. 5395-5397 (1982). |
Miyaura, N. et al., Synthetic Communications, vol. 11(7), pp. 513-519 (1982). |
Sprouse, C. et al., Abstracts of Papers, p. 32, Coresta/TCRC, Joint Conference (1972). |
Bencherif, M. et al., JPET, vol. 279, No. 3, pp. 1413-1421 (1996). |
Lippiello P. et al., JPET, vol. 279, No. 3, pp. 1422-1429 (1996). |
Baron, J.A., “Cigarette smoking and Parkinson's Disease,” Neurology, 36:1490-1496 (1986). |
Bencherif, M., et al., “RJR-2403: A Nicotinic Agonsist with CNS Selectivity I: In Vitro Characterization,” J. Pharmacol. Exper. Therapeutics, 279(3):1413-1421 (1996). |
Decina, P. et al., “Cigarette Smoking and Neuroleptic-Induced Parkinsonism,” Biol. Psychiatry, 28(6):502-508 (1990). |
Faraone, S.V., et al., “An Exploratory Study of ADHD among Second-Degree Relatives of ADHD Children,” Biol. Psychiatry, 35(6):398-402 (1994). |
Frank, W.C. et al., “Palladium-Catalyzed Vinylic Substitution Reactions with Heterocyclic Bromides,” J. Org. Chem., 43(15):2947-2949 (1978). |
Giacobini, E., “Pharmacotherapy of Alzheimer's Disease: New Drugs and Novel Strategies,” Chapter 61, pp. 529-538 in Alzheimer's Disease: Advances in Clinical and Basic Research, Ed. Corain, B., et al., John Wiley & Sons Ltd, (1993). |
Gibson, S. et al., “Principal Components Describing Biological Activities and Molecular Diversity of Heterocyclic Aromatic Ring Fragments,” J. Med. Chem., 39:4065-4072 (1996). |
Hall, G.H. and D.M. Turner, “Effects of Nicotine on the Release of 3H-Noradrenaline from the Hypothalamus,” Biochemical Pharmacology, 21:1829-1838 (1972). |
Hamon, M., “Neuropharmacology of anxiety: perspectives and prospects”; TiPS, 15:1536-1539 (1994). |
Harsing, Jr., L.G., et al., “Dopamine Efflux from Striatum After Chronic Nicotine: Evidence for Autoreceptor Desensitization,” J. Neurochem., 59:48-54 (1992). |
Henrich, H., et al., “Microcirculatory Effects of Nicotine and Related Alkaloids,” Klin Wochenschr 62(Supp. II):92-100 (1984). |
Hery, F., et al., “Control of the Release of Newly Synthetized 3H-5-Hydroxytryptamine by Nicotinic and Muscarinic Receptors in Rat Hypothalamic Slices,” Naunyn-Schmiedeberg's Arch. Pharmacol., 296:91-97 (1977). |
Jinno, S., et al., “Nicotine and acetylcholine induce release of calcitonin gene-related peptide from rat trachea,” J. Appl. Physiol., 76(4):1651-1656 (1994). |
Kontos, H.A., “Vascular diseases of the limbs,” Chapter 46, pp. 346-349 in Cardiovascular Diseases. |
Lippiello, P.M., et al., “RJR-2403: A Nicotinic Agonist with CNS Selectivity II. In Vivo Characterization,” J. Pharmacol. Exper. Therapeutics, 279(3):1422-1429 (1996). |
Newhouse, P.A. and J.R. Hughes, “The role of nicotine and nicotinic mechanisms in neuropsychiatric disease,” British J. of Addiction, 86:521-526 (1991). |
Onaivi, E.S., et al., “Chronic Nicotine Reverses Age-Associated Increases in Tail-Flick Latency and Anxiety in Rats,” Life Sciences, 54(3):193-202 (1994). |
Pomerlau, O.F., et al.; “The Effects of Cigarette Smoking on Pain and Anxiety”; Addictive Behaviors, 9:265-271 (1984). |
Pullan, R.D. et al., “Transdermal Nicotine for Active Ulcerative Colitis,” New England J. Med., 330(12):811-815 (1994). |
Rapier, C., et al., “Stereoselective Nicotine-Induced Release of Dopamine from Striatal Synaptosomes: Concentration Dependence and Repetitive Stimulation,” J. Neurochem., 50(4):1123-1130 (1988). |
Rowell, P.P. and D.L. Winkler, “Nicotinic Stimulation of [3H] Acetylcholine Release from Mouse Cerebral Cortical Synaptosomes,” J. Neurochem., 43(6):1593-1598 (1984). |
Rowell, P.P., “Current Concepts on the Effects of Nicotine on Neurotransmitter Release in the Central Nervous System,” Adv. Behav. Biol., 31:191-208 (1987). |
Sanberg, P.R. and A.A. Silver, “Beneficial Effects of Nicotine in Tourette's Syndrome”; ABSTRACT S39, Int'l Symposium on Nicotine: The Effects of Nicotine on Biological Systems II, Montreal Canada, Jul. 21-24, 1994. |
Sandor, N.T., et al. “Effect of Nicotine on dopaminergic-cholinergic interaction in the striatum,” Brain Res., 567:313-316 (1991). |
Sherwood, N., “Effects of Nicotine on Human Psychomoter Performance,” Human Psychopharmacology, 8:155-184 (1993). |
Sjak-Shie, N.N. and E.M. Meyer, “Effects of chronic nicotine and pilocarpine administration on neocortocal neuronal density and [3H]GABA uptake in nucleus basalis lesioned rats,” Brain Res., 624:295-298 (1993). |
Toth, E., et al., “Effect of Nicotine of Extracellular Levels of Neurotransmitters Assessed by Microdialysis in Various Brain Regions: Role of Glutamic Acid,” Neurochem. Res., 17(3):265-271 (1992). |
Vizi, E.S., “Acetylcholine release from guinea-pig ileum by parasympathetic ganglion stimulants and gastrin-like polypeptides,” Br. J. Pharmac., 47:765-777 (1973). |
Wagner, B., et al., “Does Smoking Reduce the Risk of Neuroleptic Parkinsonoids?,” Pharmacopsychiat., 21:302-303 (1988). |
Wilson, Jr., K.L., et al.; “Nicotine-Like Actions of cis-Metanicotine and trans-Metanicotine,” J. Pharmacol. and Exp. Ther., 196(3):685-696 (1976). |